The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

We studied 211 hyperandrogenic women with respect to clinical presentation, basal androgen levels, and the degree of cortisol and androgen suppression during a 48-h low-dose (2 mg) dexamethasone-suppression test (LDDST) to exclude ovarian and adrenal tumors. In 42 women with elevated testosterone le...

Full description

Bibliographic Details
Main Authors:	Kaltsas, G, Isidori, A, Kola, B, Skelly, R, Chew, S, Jenkins, P, Monson, J, Grossman, AB, Besser, G
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
by: Kaltsas, G, et al.
Published: (2003)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
by: Isidori, A, et al.
Published: (2003)

Discriminatory value of low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome - Response
by: Isidori, A, et al.
Published: (2004)

Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
by: Kaltsas, G, et al.
Published: (2003)

The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
by: Dias, R, et al.
Published: (2006)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
by: Monson, J, et al.
Published: (2001)

CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
by: Grossman, AB, et al.
Published: (1988)

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
by: Kaltsas, G, et al.
Published: (2002)

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
by: Florakis, D, et al.
Published: (2000)

The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.
by: Isidori, A, et al.
Published: (2006)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
by: Kaltsas, G, et al.
Published: (2001)

Secondary forms of polycystic ovary syndrome.
by: Kaltsas, G, et al.
Published: (2004)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
by: Alexandraki, K, et al.
Published: (2009)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
by: Isidori, A, et al.
Published: (2002)

Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis.
by: Storr, H, et al.
Published: (2004)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
by: Kaltsas, G, et al.
Published: (2000)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2001)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
by: Jenkins, P, et al.
Published: (2000)

The diagnosis and medical management of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2004)

Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
by: Woo, Y, et al.
Published: (2005)

DIAGNOSIS OF HYPERANDROGENISM: DIFFICULTY AND THE CONSEQUENCES
by: N. I. Volkova, et al.
Published: (2017-03-01)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Uterine leiomyomata in women with acromegaly
by: Kaltsas, G, et al.
Published: (2000)

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission.
by: Gueorguiev, M, et al.
Published: (2012)

GnRH analogue use in postmenopausal hyperandrogenism: long-term remission
by: Gueorguiev, M, et al.
Published: (2011)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
by: Kaltsas, G, et al.
Published: (1998)

Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome.
by: Rockall, A, et al.
Published: (2003)

Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.
by: Rockall, A, et al.
Published: (2003)

THE CRF TEST IN THE DIAGNOSIS OF ACTH-DEPENDENT CUSHINGS-SYNDROME - A COMPARISON WITH DEXAMETHASONE
by: Grossman, A, et al.
Published: (1987)

Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment.
by: Putignano, P, et al.
Published: (2000)

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
by: Drake, WM, et al.
Published: (1998)

Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
by: Kaltsas, G, et al.
Published: (2000)

Ectopic ACTH syndrome.
by: Isidori, A, et al.
Published: (2006)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
by: Korbonits, M, et al.
Published: (1999)

Menstrual irregularity in women with acromegaly.
by: Kaltsas, G, et al.
Published: (1999)

Androgen synthesis in menopause and diagnosis of causes of hyperandrogenism in menopause
by: О. А. Бурка, et al.
Published: (2019-12-01)

Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
by: Mukherjee, J, et al.
Published: (2001)

Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.
by: Alexandraki, K, et al.
Published: (2013)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
by: Kaltsas, G, et al.
Published: (1999)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
by: Colson, A, et al.
Published: (2008)